284 related articles for article (PubMed ID: 30012223)
1. Assessment of cross-protection induced by a bluetongue virus (BTV) serotype 8 vaccine towards other BTV serotypes in experimental conditions.
Martinelle L; Dal Pozzo F; Thys C; De Leeuw I; Van Campe W; De Clercq K; Thiry E; Saegerman C
Vet Res; 2018 Jul; 49(1):63. PubMed ID: 30012223
[TBL] [Abstract][Full Text] [Related]
2. Experimental bluetongue virus superinfection in calves previously immunized with bluetongue virus serotype 8.
Martinelle L; Dal Pozzo F; Sarradin P; Van Campe W; De Leeuw I; De Clercq K; Thys C; Thiry E; Saegerman C
Vet Res; 2016 Jul; 47(1):73. PubMed ID: 27465686
[TBL] [Abstract][Full Text] [Related]
3. Bluetongue viruses based on modified-live vaccine serotype 6 with exchanged outer shell proteins confer full protection in sheep against virulent BTV8.
van Gennip RG; van de Water SG; Maris-Veldhuis M; van Rijn PA
PLoS One; 2012; 7(9):e44619. PubMed ID: 23049753
[TBL] [Abstract][Full Text] [Related]
4. Bluetongue in Spain: from the first outbreak to 2012.
de Diego AC; Sánchez-Cordón PJ; Sánchez-Vizcaíno JM
Transbound Emerg Dis; 2014 Dec; 61(6):e1-11. PubMed ID: 23480789
[TBL] [Abstract][Full Text] [Related]
5. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
[TBL] [Abstract][Full Text] [Related]
6. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
Feenstra F; Pap JS; van Rijn PA
Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.
Bréard E; Belbis G; Hamers C; Moulin V; Lilin T; Moreau F; Millemann Y; Montange C; Sailleau C; Durand B; Desprat A; Viarouge C; Hoffmann B; de Smit H; Goutebroze S; Hudelet P; Zientara S
Vaccine; 2011 Mar; 29(13):2495-502. PubMed ID: 21256877
[TBL] [Abstract][Full Text] [Related]
8. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep.
Zulu GB; Venter EH
J S Afr Vet Assoc; 2014 Oct; 85(1):1041. PubMed ID: 25686101
[TBL] [Abstract][Full Text] [Related]
10. VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA.
Feenstra F; Maris-Veldhuis M; Daus FJ; Tacken MG; Moormann RJ; van Gennip RG; van Rijn PA
Vaccine; 2014 Dec; 32(52):7108-14. PubMed ID: 25454873
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle.
Anderson J; Hägglund S; Bréard E; Comtet L; Lövgren Bengtsson K; Pringle J; Zientara S; Valarcher JF
Clin Vaccine Immunol; 2013 Aug; 20(8):1115-22. PubMed ID: 23720365
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines.
Breard E; Belbis G; Viarouge C; Nomikou K; Haegeman A; De Clercq K; Hudelet P; Hamers C; Moreau F; Lilin T; Durand B; Mertens P; Vitour D; Sailleau C; Zientara S
Vaccine; 2015 Jan; 33(4):512-8. PubMed ID: 25500308
[TBL] [Abstract][Full Text] [Related]
13. Clinical disease in sheep caused by bluetongue virus serotype 8, and prevention by an inactivated vaccine.
Moulin V; Noordegraaf CV; Makoschey B; van der Sluijs M; Veronesi E; Darpel K; Mertens PP; de Smit H
Vaccine; 2012 Mar; 30(12):2228-35. PubMed ID: 22207091
[TBL] [Abstract][Full Text] [Related]
14. Vaccines against bluetongue in Europe.
Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
[TBL] [Abstract][Full Text] [Related]
15. Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage.
Zhugunissov K; Bulatov Y; Taranov D; Yershebulov Z; Koshemetov Z; Zhunushov A; Renukaradhya GJ; Tabynov K; Abduraimov Y
Vet Microbiol; 2018 Nov; 226():23-30. PubMed ID: 30389040
[TBL] [Abstract][Full Text] [Related]
16. Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines.
Celma CC; Stewart M; Wernike K; Eschbaumer M; Gonzalez-Molleda L; Breard E; Schulz C; Hoffmann B; Haegeman A; De Clercq K; Zientara S; van Rijn PA; Beer M; Roy P
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795442
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy of commercial vaccines against bluetongue virus serotypes 1 and 8 in experimentally infected red deer (Cervus elaphus).
Lorca-Oró C; López-Olvera JR; Fernández-Sirera L; Solanes D; Navarro N; García-Bocanegra I; Lavín S; Domingo M; Pujols J
Vet Microbiol; 2012 Jan; 154(3-4):240-6. PubMed ID: 21824733
[TBL] [Abstract][Full Text] [Related]
18. A one-year follow-up of antibody response in cattle and sheep after vaccination with serotype 8- and serotype 1-inactivated BT vaccines.
Zanella G; Bréard E; Sailleau C; Zientara S; Viarouge C; Durand B
Transbound Emerg Dis; 2014 Oct; 61(5):473-6. PubMed ID: 23331382
[TBL] [Abstract][Full Text] [Related]
19. Colostral antibody induced interference of inactivated bluetongue serotype-8 vaccines in calves.
Vitour D; Guillotin J; Sailleau C; Viarouge C; Desprat A; Wolff F; Belbis G; Durand B; Bakkali-Kassimi L; Breard E; Zientara S; Zanella G
Vet Res; 2011 Feb; 42(1):18. PubMed ID: 21314901
[TBL] [Abstract][Full Text] [Related]
20. Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection.
Kochinger S; Renevey N; Hofmann MA; Zimmer G
Vet Res; 2014 Jun; 45(1):64. PubMed ID: 24928313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
